{"id":58164,"date":"2023-10-05T19:05:12","date_gmt":"2023-10-05T17:05:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/"},"modified":"2023-10-05T19:05:12","modified_gmt":"2023-10-05T17:05:12","slug":"biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/","title":{"rendered":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts"},"content":{"rendered":"
\n

\n\u201cLightning talk\u201d session will highlight how the Company\u2019s ExoVita\u2122 Pancreas test can be used to stratify IPMN risk to inform treatment decisions<\/i><\/p>\n

SAN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc.<\/a>, a leader in exosome enrichment technology for early disease detection, will present a \u201clightning talk\u201d as part of the \u201cUnderstanding Pre-cancers to Enable Early Detection\u201d track at the Early Detection of Cancer Conference<\/a>, Oct. 10-12, 2023, in London. The session will demonstrate the ability of the ExoVita Pancreas assay to risk-stratify Intraductal Papillary Mucinous Neoplasms (IPMNs), the most common type of pancreatic cyst, in order to help inform treatment decisions for patients at risk of pancreatic cancer.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe talk, \u201cProteomic Expression Using Exosomes in Intraductal Papillary Mucinous Neoplasms (IPMN) Patients to Inform Risk Stratification,” will be presented by Harmeet Dhani, MD, MSc, Medical Director, Biological Dynamics, and is scheduled for Tuesday, Oct. 10, from 4:50 to 5:20 p.m. GMT+1 and will be followed by a 10-minute panel Q&A session.<\/p>\n

\n\u201cWith support from leading collaborators, we have made substantial progress toward providing physicians with a clinical tool for early detection and risk-stratification of IPMNs,\u201d said Dr. Dhani. \u201cWe are confident that ExoVita Pancreas, which is powered by our ExoVerita exosome-isolation technology, has strong potential to inform treatment decisions for patients, including whether to undergo surgery or adopt a \u2018watch-and-wait\u2019 strategy.\u201d<\/p>\n

\nPancreatic cancer is the third deadliest cancer in the U.S., with a 5-year survival rate of merely 12.5%. Pancreatic cysts, such as IPMNs, affect as many as 750,000 Americans and are more likely to develop with age. The ExoVita Pancreas assay leverages Biological Dynamics\u2019 proprietary Verita\u2122 technology, a novel platform that enriches exosomes and facilitates proteomic analysis. This powerful method provides high-sensitivity detection of pancreatic cancer in its early stages, resulting in improved treatment options for this deadly disease. Biological Dynamics is partnering with the PRECEDE consortium to validate the ExoVita Pancreas assay for both IPMNs and other patients at high risk for developing cancer.<\/p>\n

\nAbout Biological Dynamics<\/b><\/p>\n

\nBiological Dynamics, Inc., is a leader in exosome-isolation technology committed to improving global health outcomes by identifying early-stage disease. Its ExoVerita\u2122 platform offers a simple and automated workflow to enrich for exosomes, powering advanced detection tests for some of the most challenging diseases. Biological Dynamics\u2019 ExoVita\u2122 assays utilize the ExoVerita platform to enable reliable surveillance and early cancer detection to help enhance and extend lives. Learn more at www.BiologicalDynamics.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Andrea Sampson, Sampson Public Relations Group
\n
asampson@sampsonprgroup.com<\/a>
562-304-0301<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u201cLightning talk\u201d session will highlight how the Company\u2019s ExoVita\u2122 Pancreas test can be used to stratify IPMN risk to inform treatment decisions SAN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a \u201clightning talk\u201d as part of the \u201cUnderstanding Pre-cancers to Enable Early Detection\u201d track at the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58164","6":"format-standard","7":"category-industry"},"yoast_head":"\nBiological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u201cLightning talk\u201d session will highlight how the Company\u2019s ExoVita\u2122 Pancreas test can be used to stratify IPMN risk to inform treatment decisions SAN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a \u201clightning talk\u201d as part of the \u201cUnderstanding Pre-cancers to Enable Early Detection\u201d track at the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-05T17:05:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts\",\"datePublished\":\"2023-10-05T17:05:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/\"},\"wordCount\":434,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231005100284\\\/en\\\/1907900\\\/21\\\/Biological_Dynamics.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/\",\"name\":\"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231005100284\\\/en\\\/1907900\\\/21\\\/Biological_Dynamics.jpg\",\"datePublished\":\"2023-10-05T17:05:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231005100284\\\/en\\\/1907900\\\/21\\\/Biological_Dynamics.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231005100284\\\/en\\\/1907900\\\/21\\\/Biological_Dynamics.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/","og_locale":"en_US","og_type":"article","og_title":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend","og_description":"\u201cLightning talk\u201d session will highlight how the Company\u2019s ExoVita\u2122 Pancreas test can be used to stratify IPMN risk to inform treatment decisions SAN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a \u201clightning talk\u201d as part of the \u201cUnderstanding Pre-cancers to Enable Early Detection\u201d track at the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-05T17:05:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts","datePublished":"2023-10-05T17:05:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/"},"wordCount":434,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/","url":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/","name":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg","datePublished":"2023-10-05T17:05:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231005100284\/en\/1907900\/21\/Biological_Dynamics.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biological-dynamics-to-share-data-at-2023-early-detection-of-cancer-conference-in-london-highlighting-value-of-exosome-based-liquid-biopsy-assay-in-detecting-pancreatic-cysts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biological Dynamics to Share Data at 2023 Early Detection of Cancer Conference in London, Highlighting Value of Exosome-based Liquid Biopsy Assay in Detecting Pancreatic Cysts"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58164"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58164\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}